Skip to main content
Top
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Research article

Characteristics of undiagnosed diseases network applicants: implications for referring providers

Authors: Nicole M. Walley, Loren D. M. Pena, Stephen R. Hooper, Heidi Cope, Yong-Hui Jiang, Allyn McConkie-Rosell, Camilla Sanders, Kelly Schoch, Rebecca C. Spillmann, Kimberly Strong, Alexa T. McCray, Paul Mazur, Cecilia Esteves, Kimberly LeBlanc, Anastasia L. Wise, Vandana Shashi, Undiagnosed Diseases Network

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

The majority of undiagnosed diseases manifest with objective findings that warrant further investigation. The Undiagnosed Diseases Network (UDN) receives applications from patients whose symptoms and signs have been intractable to diagnosis; however, many UDN applicants are affected primarily by subjective symptoms such as pain and fatigue. We sought to characterize presenting symptoms, referral sources, and demographic factors of applicants to the UDN to identify factors that may determine application outcome and potentially differentiate between those with undiagnosed diseases (with more objective findings) and those who are less likely to have an undiagnosed disease (more subjective symptoms).

Methods

We used a systematic retrospective review of 151 consecutive Not Accepted and 50 randomly selected Accepted UDN applications. The primary outcome was whether an applicant was Accepted, or Not Accepted, and, if accepted, whether or not a diagnosis was made. Objective and subjective symptoms and information on prior specialty consultations were collected from provider referral letters. Demographic data and decision data on network acceptance were gathered from the UDN online portal.

Results

Fewer objective findings and more subjective symptoms were found in the Not Accepted applications. Not Accepted referrals also were from older individuals, reported a shorter period of illness, and were referred to the UDN by their primary care physicians. All of these differences reached statistical significance in comparison with Accepted applications. The frequency of subspecialty consults for diagnostic purposes prior to UDN application was similar in both groups.

Conclusions

The preponderance of subjective and lack of objective findings in the Not Accepted applications distinguish these from applicants that are accepted for evaluation and diagnostic efforts through the UDN. Not Accepted applicants are referred primarily by their primary care providers after multiple specialist consultations fail to yield answers. Distinguishing between patients with undiagnosed diseases with objective findings and those with primarily subjective findings can delineate patients who would benefit from further diagnostic processes from those who may have functional disorders and need alternative pathways for management of their symptoms.

Trial registration

clinicaltrials.gov NCT02450851, posted May 21st 2015.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gahl WA, Wise AL, Ashley EA. The undiagnosed diseases network of the National Institutes of Health: a National Extension. JAMA. 2015;314(17):1797–8.CrossRefPubMed Gahl WA, Wise AL, Ashley EA. The undiagnosed diseases network of the National Institutes of Health: a National Extension. JAMA. 2015;314(17):1797–8.CrossRefPubMed
3.
go back to reference Ramoni RB, Mulvihill JJ, Adams DR, et al. The undiagnosed diseases network: accelerating discovery about health and disease. Am J Hum Genet. 2017;100(2):185–92.CrossRefPubMedPubMedCentral Ramoni RB, Mulvihill JJ, Adams DR, et al. The undiagnosed diseases network: accelerating discovery about health and disease. Am J Hum Genet. 2017;100(2):185–92.CrossRefPubMedPubMedCentral
4.
go back to reference Nettleton S, Watt I, O'Malley L, Duffey P. Understanding the narratives of people who live with medically unexplained illness. Patient Educ Couns. 2005;56(2):205–10.CrossRefPubMed Nettleton S, Watt I, O'Malley L, Duffey P. Understanding the narratives of people who live with medically unexplained illness. Patient Educ Couns. 2005;56(2):205–10.CrossRefPubMed
5.
go back to reference McAndrew LM, Phillips LA, Helmer DA, et al. High healthcare utilization near the onset of medically unexplained symptoms. J Psychosom Res. 2017;98:98–105.CrossRefPubMed McAndrew LM, Phillips LA, Helmer DA, et al. High healthcare utilization near the onset of medically unexplained symptoms. J Psychosom Res. 2017;98:98–105.CrossRefPubMed
6.
go back to reference Eriksen HR, Ursin H. Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res. 2004;56(4):445–8.CrossRefPubMed Eriksen HR, Ursin H. Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res. 2004;56(4):445–8.CrossRefPubMed
7.
go back to reference Nettleton S. 'I just want permission to be ill': towards a sociology of medically unexplained symptoms. Soc Sci Med. 2006;62(5):1167–78.CrossRefPubMed Nettleton S. 'I just want permission to be ill': towards a sociology of medically unexplained symptoms. Soc Sci Med. 2006;62(5):1167–78.CrossRefPubMed
8.
go back to reference Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Deutsches Arzteblatt Int. 2015;112(16):279–87. Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Deutsches Arzteblatt Int. 2015;112(16):279–87.
9.
go back to reference Rasmussen EB. Balancing medical accuracy and diagnostic consequences: diagnosing medically unexplained symptoms in primary care. Sociol Health Illn. 2017;39(7):1227–41.CrossRefPubMed Rasmussen EB. Balancing medical accuracy and diagnostic consequences: diagnosing medically unexplained symptoms in primary care. Sociol Health Illn. 2017;39(7):1227–41.CrossRefPubMed
10.
go back to reference Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ. 1998;316(7131):582–6.CrossRefPubMedPubMedCentral Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ. 1998;316(7131):582–6.CrossRefPubMedPubMedCentral
11.
go back to reference Konnopka A, Kaufmann C, Konig HH, et al. Association of costs with somatic symptom severity in patients with medically unexplained symptoms. J Psychosom Res. 2013;75(4):370–5.CrossRefPubMed Konnopka A, Kaufmann C, Konig HH, et al. Association of costs with somatic symptom severity in patients with medically unexplained symptoms. J Psychosom Res. 2013;75(4):370–5.CrossRefPubMed
12.
go back to reference Konnopka A, Schaefert R, Heinrich S, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81(5):265–75.CrossRefPubMed Konnopka A, Schaefert R, Heinrich S, et al. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom. 2012;81(5):265–75.CrossRefPubMed
13.
go back to reference Chaturvedi SK, Desai G. Measurement and assessment of somatic symptoms. Int Rev Psychiatry (Abingdon, England). 2013;25(1):31–40.CrossRef Chaturvedi SK, Desai G. Measurement and assessment of somatic symptoms. Int Rev Psychiatry (Abingdon, England). 2013;25(1):31–40.CrossRef
14.
go back to reference Burton C, McGorm K, Richardson G, Weller D, Sharpe M. Healthcare costs incurred by patients repeatedly referred to secondary medical care with medically unexplained symptoms: a cost of illness study. J Psychosom Res. 2012;72(3):242–7.CrossRefPubMed Burton C, McGorm K, Richardson G, Weller D, Sharpe M. Healthcare costs incurred by patients repeatedly referred to secondary medical care with medically unexplained symptoms: a cost of illness study. J Psychosom Res. 2012;72(3):242–7.CrossRefPubMed
15.
go back to reference Spillmann RC, McConkie-Rosell A, Pena L, et al. A window into living with an undiagnosed disease: illness narratives from the undiagnosed diseases network. Orphanet J Rare Dis. 2017;12(1):71.CrossRefPubMedPubMedCentral Spillmann RC, McConkie-Rosell A, Pena L, et al. A window into living with an undiagnosed disease: illness narratives from the undiagnosed diseases network. Orphanet J Rare Dis. 2017;12(1):71.CrossRefPubMedPubMedCentral
16.
go back to reference Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119(7):964–79.CrossRefPubMed Angelis A, Tordrup D, Kanavos P. Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy. 2015;119(7):964–79.CrossRefPubMed
17.
go back to reference Eurordis. Rare Diseases: Understanding this public health priority. wwweurordisorg. 2005. Eurordis. Rare Diseases: Understanding this public health priority. wwweurordisorg. 2005.
18.
go back to reference Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. "is it going to hurt?": the impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24(2):325–35.CrossRefPubMed Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. "is it going to hurt?": the impact of the diagnostic odyssey on children and their families. J Genet Couns. 2015;24(2):325–35.CrossRefPubMed
19.
go back to reference Shashi V, McConkie-Rosell A, Rosell B, et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med. 2014;16(2):176–82.CrossRefPubMed Shashi V, McConkie-Rosell A, Rosell B, et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med. 2014;16(2):176–82.CrossRefPubMed
20.
go back to reference Hamilton WT, Gallagher AM, Thomas JM, White PD. Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care. Psychol Med. 2009;39(11):1913–21.CrossRefPubMed Hamilton WT, Gallagher AM, Thomas JM, White PD. Risk markers for both chronic fatigue and irritable bowel syndromes: a prospective case-control study in primary care. Psychol Med. 2009;39(11):1913–21.CrossRefPubMed
21.
go back to reference Moss-Morris R, Spence M. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med. 2006;68(3):463–9.CrossRefPubMed Moss-Morris R, Spence M. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? Psychosom Med. 2006;68(3):463–9.CrossRefPubMed
22.
go back to reference Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497–505.CrossRefPubMed Kato K, Sullivan PF, Evengard B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med. 2009;39(3):497–505.CrossRefPubMed
23.
go back to reference Chong JX, Buckingham KJ, Jhangiani SN, et al. The genetic basis of Mendelian phenotypes: discoveries, challenges, and Opportunities. Am J Hum Genet. 2015; Chong JX, Buckingham KJ, Jhangiani SN, et al. The genetic basis of Mendelian phenotypes: discoveries, challenges, and Opportunities. Am J Hum Genet. 2015;
24.
go back to reference Hoedeman R, Blankenstein AH, Van der Feltz-Cornelis CM, Krol B, Stewart R, Groothoff JW. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010;(12):Cd006524. Hoedeman R, Blankenstein AH, Van der Feltz-Cornelis CM, Krol B, Stewart R, Groothoff JW. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010;(12):Cd006524.
25.
go back to reference Zarovnaya EL, Pallatroni HF, Hug EB, et al. Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. JNeurooncol. 2007;84(1):49.CrossRef Zarovnaya EL, Pallatroni HF, Hug EB, et al. Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature. JNeurooncol. 2007;84(1):49.CrossRef
Metadata
Title
Characteristics of undiagnosed diseases network applicants: implications for referring providers
Authors
Nicole M. Walley
Loren D. M. Pena
Stephen R. Hooper
Heidi Cope
Yong-Hui Jiang
Allyn McConkie-Rosell
Camilla Sanders
Kelly Schoch
Rebecca C. Spillmann
Kimberly Strong
Alexa T. McCray
Paul Mazur
Cecilia Esteves
Kimberly LeBlanc
Anastasia L. Wise
Vandana Shashi
Undiagnosed Diseases Network
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3458-2

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue